Nasdaq determined that, for the 10 consecutive business days from April 6, 2026 to April 17, 2026, the closing bid price of the Company’s common stock was at or above $1.00 per share. Accordingly, ...

Dr. Daniels is a seasoned biotechnology executive with more than two decades of experience spanning clinical development, regulatory strategy, corporate operations, and business development. He most ...

A look at the shareholders of 5N Plus Inc. (TSE:VNP) can tell us which group is most powerful. The group holding the most number of shares in the company, around 52% to be precise, is institutions.

AI, connectivity, observation and security needs fueling strong demand for solar cell technology MONTREAL, Feb. 2, 2026 /CNW/ - 5N Plus Inc. (TSX: VNP) ("5N+" or the "Company"), a leading global ...

Plus Therapeutics, Inc. announced that it will provide a business update on June 26, 2025, before the market opens. The management team will host a conference call and webcast at 9:00 a.m. ET to ...

Foxx Life Sciences, a biotech startup in Salem, has found at least part of a solution to building a workforce. The company, whose custom bag, carboy and bottle single-use assemblies are used by ...

MONTRÉAL, Feb. 24, 2026 /CNW/ - 5N Plus Inc. (TSX: VNP) ("5N+" or "the Company"), a leading global producer of specialty semiconductors and performance materials, today announced its financial results ...

CHICAGO--(BUSINESS WIRE)--Independence Plus, Inc. (IPI) announced that two and one-half years after coming on board as CEO, Danilo Coité, MD, is buying into the company, a move that supports a plan ...